Biophysiologic Outcomes of the Enhancing Adherence in Type 2 Diabetes (ENHANCE) Trial

Journal of the Academy of Nutrition and Dietetics

Volumn 112, Issue 8, 2012, Pages 1147-1157

  Sevick, Mary Ann ^a,b   Korytkowski, Mary ^c   Stone, Roslyn A ^d   Piraino, Beth ^c   Ren, Dianxu ^d   Sereika, Susan ^d   Wang, Yuanyuan ^e   Steenkiste, Ann ^f   Burke, Lora E ^d  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^e SYNEOS HEALTH   (United States)

^f Veterans Research Foundation of Pittsburgh   (United States)

Author keywords

Chronic kidney disease; Computers, hand held; Diabetes mellitus, type 2; Personal digital assistant; Randomized clinical trial

Indexed keywords

GLYCOSYLATED HEMOGLOBIN; LIPID;

ADULT; AGED; ARTICLE; BLOOD; BLOOD GLUCOSE MONITORING; BODY MASS; CARDIOVASCULAR DISEASE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC NEPHROPATHY; FEMALE; GLOMERULUS FILTRATION RATE; GLUCOSE BLOOD LEVEL; HUMAN; MALE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; PATIENT COMPLIANCE; PATIENT EDUCATION; RANDOMIZED CONTROLLED TRIAL; SELF CARE; TREATMENT OUTCOME;

ADULT; AGED; BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COGNITIVE THERAPY; DIABETES MELLITUS, TYPE 2; DIABETIC NEPHROPATHIES; FEMALE; GLOMERULAR FILTRATION RATE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LIPIDS; MALE; MIDDLE AGED; PATIENT COMPLIANCE; PATIENT EDUCATION AS TOPIC; SELF CARE; TREATMENT OUTCOME;

EID: 84864149236     PISSN: 22122672     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jand.2012.05.008     Document Type: Article

References (24)

1. National diabetes fact sheet: National estimates and general information on diabetes and prediabetes in the United States Centers for Disease Control and Prevention, Accessed May 9, 2012. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf.
2. USRDS 2009 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States 2009, US Renal Data System, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD.
3. Matsushita K., van der Velde M., Astor B.C., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: A collaborative meta-analysis. Lancet 2010, 375(9731):2073-2081.
4. Bello A.K., Hemmelgarn B., Lloyd A., et al. Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes. Clin J Am Soc Nephrol 2011, 6(6):1418-1426.
5. Standard of Medical Care in Diabetes-2011. Diabetes Care 2011, 34(suppl 1):S11-S61. American Diabetes Association.
6. Dluhy R.G., McMahon G.T. Intensive glycemic control in the ACCORD and ADVANCE Trials. N Engl J Med 2008, 358(24):2630-2633.
7. Duckworth W., Abraira C., Moritz T., et al. Glucose control and vascular complications in veterans with type 2 diabetes. N Engl J Med 2009, 360(2):129-139.
8. Effects of intensive blood pressure control in type 2 diabetes mellitus. N Engl J Med 2010, 363(3):233-244. The ACCORD Study Group.
9. The effects of combination lipid therapy in type 2 diabetes mellitus. N Engl J Med 2010, 362(17):1563-1574. The ACCORD Study Group.
10. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med 2008, 358(24):2545-2559. The Action to Control Cardiovascular Risk in Diabetes Study Group.
11. Effects of combination lipid therapy on cardiovascular events in type 2 diabetes mellitus: The ACCORD lipid study [Press release video March 14, 2010.], Accessed February 21, 2012. http://www.cardiosource.org/News-Media/Meeting-Coverage/ACC/ACC-2010.aspx.
12. Effects of intensive blood pressure control on cardiovascular events in type 2 diabetes mellitus: The ACCORD blood pressure trial [Press release video March 14, 2010.], Accessed February 21, 2012. http://www.cardiosource.org/News-Media/Meeting-Coverage/ACC/ACC-2010.aspx.
13. Bandura A. Self Efficacy: The Exercise of Control 1997, Freeman and Co, New York, NY.
14. USDA National Nutrient Database for Standard Reference Accessed February 21, 2012. http://ndb.nal.usda.gov/.
15. Vessby, Uusitupa M., Hermansen K., et al. Substituting dietary saturated for monounsaturated fat impairs insulin sensitivity in healthy men and women: The KANWU study. Diabetologia 2001, 44(3):312-319.
16. Sevick M.A., Stone R.A., Zickmund S., Wang Y., Korytkowski M., Burke L.E. Factors associated with probability of personal digital assistant-based dietary self-monitoring in those with type 2 diabetes. J Behav Med 2010, 33(4):315-325.
17. Sevick M.A., Zickmund S., Korytkowski M., et al. Design, feasibility, and acceptability of an intervention using personal digital assistant-based self-monitoring in managing type 2 diabetes. Contemp Clin Trials 2008, 29(3):396-409.
18. Cohen J. Statistical Power Analysis for the Behavioral Sciences 1998, Lawrence Erlbaum Associates, Hillsdale, NJ. 2nd ed.
19. Moher D., Hopewell S., Schulz K.F., et al. CONSORT 2010 explanation and elaboration: Updated guidelines for reporting parallel group randomized trials. J Clin Epidemiol 2010, 63(8):813-814.
20. Ismail K., Winkley K., Rabe-Hesketh S. Systematic review and meta-analysis of randomized controlled trials of psychological interventions to improve glycaemic control in patients with type 2 diabetes. Lancet 2004, 363(9421):1589-1597.
21. 1c standardization: Background, progress and current issues. LabMedicine 2009, 40:368-373.
22. St John A., Davis W.A., Price C.P., Davis T.M. The value of self-monitoring of blood glucose: A review of recent evidence. J Diabetes Complications 2010, 24(2):129-141.
23. Alleman S., Houriet C., Diem P., Stettler C. Self-monitoring of blood glucose in non-insulin treated patients with type 2 diabetes: A systematic review and meta-analysis. Curr Med Res Opin 2009, 25(12):2903-2913.
24. McGeoch G., Derry S., Moore R.A. Self-monitoring of blood glucose in type-2 diabetes: What is the evidence?. Diabetes Metab Res Rev 2007, 23(6):423-440.